Rankings
▼
Calendar
ONC
BeOne Medicines Ltd.
$33B
Q2 2023 Earnings
Healthcare
Medical - Pharmaceuticals
Income Statement
Revenue
$595M
+74.3% YoY
Gross Profit
$499M
83.9% margin
Operating Income
-$319M
-53.5% margin
Net Income
-$381M
-64.0% margin
EPS (Diluted)
$-3.64
QoQ Revenue Growth
+32.9%
Cash Flow
Operating Cash Flow
-$294M
Free Cash Flow
-$415M
Stock-Based Comp.
$103M
Balance Sheet
Total Assets
$5.7B
Total Liabilities
$1.9B
Stockholders' Equity
$3.8B
Cash & Equivalents
$3.4B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$595M
$342M
+74.3%
Gross Profit
$499M
$270M
+84.6%
Operating Income
-$319M
-$439M
+27.5%
Net Income
-$381M
-$566M
+32.6%
← FY 2023
All Quarters
Q3 2023 →
ONC Q2 2023 Earnings — BeOne Medicines Ltd. Revenue & Financial Results | Market Cap Arena